We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

But Moderna shares later surged after Oracle Chairman Larry Ellison called out the speed ... than 8% after Oracle's Ellison said mRNA-based cancer vaccines could be developed in under 48 hours with ...

It was an illuminating moment, not just an amusing line. Every new administration has factions that end up hating one another despite being on the same official team. But the second Trump White House ...

In a groundbreaking announcement, former President Donald Trump has unveiled an ambitious $500 billion plan aimed at pioneering a cancer vaccine that could change the landscape of treatment for ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

In 2025, the AI landscape is undergoing a transformative shift, expanding into two critical new layers: the application layer ...

The article continued: Recently Spotify's founder Daniel Ek's new HealthTech startup Neko Health secured a $260 million financing, valuing the company at approximately $1.8 billion. As part of the ...

One day after being sworn in as the 47th president of the United States, Donald Trump revealed the creation of Stargate, a ...

Leerink Partners analyst Mani Foroohar has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Invest with ...

A scene from the first week of the second Trump administration: After the president held a White House event announcing a ...

“Successful self-replication under no human assistance is the essential step for AI to outsmart [humans], and is an early ...

From left: Masayoshi Son, chairman and CEO of SoftBank; Larry Ellison, executive chairman of Oracle; and Sam Altman, CEO of OpenAI listen to President Trump speak at the White House on Jan. 21 ...